Dividend Aristocrats Part 30: Abbott Laboratories

Abbott Laboratories’ stock has only risen 4.8% in the last year due to a strong United States dollar. The strong dollar hurts the company’s reported results as it must translate its earnings back to dollars.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.